┌──────────────────────────────────────────────────────────────┐ RECORD TYPE ......... SUBJECT FILE SUBJECT TYPE ........ ORG FILE OPENED ......... 2026-07-06 00:17 UTC APPEARANCES ......... 3 ANNOTATIONS KNOWN ALIASES ....... 2 └──────────────────────────────────────────────────────────────┘
Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP)
ALSO APPEARS AS
- JAACAP
- Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP)
APPEARS IN THE MARGINS OF
- Medical Guidance on Paroxetine for Adolescents and Study 329 Reference (2001-2015)
Following the 2001 publication of Study 329, an influential clinical trial on the antidepressant paroxetine (Paxil/Seroxat) for adolescent depression, questions arose regarding its efficacy and safety…
- Study 329's Impact on Adolescent Antidepressant Prescriptions
Study 329, a clinical trial evaluating paroxetine and imipramine for adolescent major depression, was originally published in 2001, claiming efficacy and safety for paroxetine [1]. This original publi…
- Journal of the American Academy of Child and Adolescent Psychiatry Pre-2015 Ghostwriting Policies
This dossier investigates whether the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), the original publisher of Study 329, had explicit editorial policies or communication…